Abstract:Background: Randomized trials have yielded mixed results on the effects of treatment for Helicobacter pylori and little information on the effects of vitamins or garlic supplements on precancerous gastric lesions. We conducted a randomized trial to test the effects of one-time H. pylori treatment and long-term vitamin or garlic supplements in reducing the prevalence of advanced precancerous gastric lesions. Methods: Most of the adults aged 35-64 years in 13 randomly selected villages in Linqu County, Shandong Province, China, were identified and given baseline endoscopies in 1994. In 1995, 3365 eligible subjects were randomly assigned in a factorial design to three interventions or placebos: amoxicillin and omeprazole for 2 weeks in 1995 (H. pylori treatment); vitamin C, vitamin E, and selenium for 7.3 years (vitamin supplement); and aged garlic extract and steam-distilled garlic oil for 7.3 years (garlic supplement). Subjects underwent endoscopies with biopsies in 1999 and 2003, and the prevalence of precancerous gastric lesions was determined by histopathologic examination of seven standard biopsy sites. The 3365 eligible randomized subjects represented 93.5% of those with baseline endoscopy and included all baseline histologic categories except gastric cancer. Only 0.18% had normal gastric mucosa. Logistic regression was used to estimate the intervention effects on the odds of advanced precancerous gastric lesions, and t-tests were used to assess effects on histologic severity. All statistical tests were two-sided. Results: H. pylori treatment resulted in statistically significant decreases in the combined prevalence of severe chronic atrophic gastritis, intestinal metaplasia, dysplasia, or gastric cancer in 1999 (odds ratio [OR] = 0.77; 95% confidence interval [CI] = 0.62 to 0.95) and in 2003 (OR = 0.60; 95% Cl = 0.47 to 0.75), and had favorable effects on the average histopathologic severity and on progression and regression of precancerous gastric lesions in 2003. H. pylori treatment did not reduce the combined prevalence of dysplasia or gastric cancer. However, fewer subjects receiving H. pylori treatment (19/1130; 1.7%) than receiving placebo (27/1128; 2.4%) developed gastric cancer (adjusted P=.14). No statistically significant favorable effects were seen for garlic or vitamin supplements. Conclusion: H. pylori treatment reduces the prevalence of precancerous gastric lesions and may reduce gastric cancer incidence, but further data are needed to prove the latter point. Long-term vitamin or garlic supplementation had no beneficial effects on the prevalence of precancerous gastric lesions or on gastric cancer incidence.

Quality of RCTs Exploringhelicobacter Pylorieradication for the Prevention of Gastric Cancer and Preneoplastic Lesions

Helicobacter pylori eradication therapy for functional dyspepsia: Systematic review and meta-analysis.

Effect of Helicobacter Pylori Eradication on Hyperplastic Gastric Polyps: A Systematic Review and Meta‐analysis

Efficacy of quadruple therapy with clarithromycin based on faecal molecular antimicrobial susceptibility tests as first-line treatment for <i>Helicobacter pylori</i> infection: a protocol of a single-centre, single-blind, randomised clinical trial in China

Effect of Drug Treatment on Hyperplastic Gastric Polyps Infected with Helicobacter Pylori: A Randomized, Controlled Trial

The Effect Ofhelicobacter Pylorieradication in Patients with Gastroesophageal Reflux Disease: A Meta-Analysis of Randomized Controlled Studies

Cost-Effectiveness Analysis of Helicobacter Pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model

DoesHelicobacter Pylorieradication Really Reduce the Risk of Gastric Cancer at the Population Level?

Gastric Cancer Prevention by Community Eradication of Helicobacter Pylori: a Cluster-Randomized Controlled Trial

Overview of Methodological Quality of Systematic Reviews about Gastric Cancer Risk and Protective Factors

The Impact of Helicobacter Pylori Infection, Eradication Therapy and Probiotic Supplementation on Gut Microenvironment Homeostasis: an Open-Label, Randomized Clinical Trial

Effect of Helicobacter pylori Eradication on Gastric Cancer Prevention: Updated Report From a Randomized Controlled Trial With 26.5 Years of Follow-Up

Systematic Review And Meta-Analysis From Chinese Literature: The Association Between Helicobacter Pylori Eradication And Improvement Of Functional Dyspepsia

Health Economic Evaluation on Population-Based Helicobacter Pylori Eradication and Endoscopic Screening for Gastric Cancer Prevention.

Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis

Therapeutic Effects of Eradicating Helicobacter Pylori on Gastric Hyperplastic Polyps

Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis

The Effect of <b><i>helicobacter Pylori</i></b> Eradication in Patients with Gastroesophageal Reflux Disease: A Meta-Analysis of Randomized Controlled Studies

Helicobacter pylori eradication for primary prevention of gastric cancer: progresses and challenges

Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.

A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication.